Skip to main content
SpringerLink
Log in

Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Peripheral nervous system alterations were induced in adult rats by administration of cisplatin (CDDP) 2 mg/kg twice weekly for 4.5 weeks. Dorsal root ganglion neurons showed pathological changes. Morphometric determinations demonstrated a reduction in size of the somatic, nuclear and nucleolar area. The nucleoli were the most involved subcellular structures. Nerve conduction velocity and the tail-flick test for pain were both significantly altered in CDDP treated rats, whereas the rota-rod test for coordination revealed no changes in either treated or control rats. Analytical determinations demonstrated platinum accumulation in the DRG of CDDP treated rats. Spontaneous recovery, demonstrated by morphometric, electrophysiological, functional and analytical determinations, occurred after treatment discontinuation within about 7 weeks. A pilot study of the possible neuroprotective action of retinoic acid (RA) was also performed with this model of cisplatin neuronopathy. The rationale for using RA was based on its assumed antioxidant and neurotrophic effect. However, RA failed to prevent morphometric, electrophysiological, functional and analytical alterations induced by CDDP on DRG neurons. RA induced only a mild generalized protective effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mollman JE: Cisplatin neurotoxicity. N Engl J Med 322: 126–127, 1990

    Google Scholar 

  2. Cavaletti G, Marzorati L, Bogliun G, Colombo N, Marzola M, Pittelli MR, Tredici G: Cisplatin peripheral neurotoxicity is not only total dose but also single dose intensity-dependent. Cancer 69: 203–207, 1992

    Google Scholar 

  3. Thompson SW, Dawis LE, Kornfield M, Hilgers RD, Standeffer JC: Cisplatin neuropathy: clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer 54: 1269–1275, 1984

    Google Scholar 

  4. Tomiwa K, Nolan C, Cavanagh JB: The effect of cisplatin on the rat spinal ganglia: a study by light and electron microscopy and by morphometry. Acta Neuropathol 69: 295–308, 1986

    Google Scholar 

  5. Müller LJ, Geritsen van der Hoop R, Moorer-van Delft C, Gispen WH, Roubos EW: Morphological and electrophysiological study of the effects of cisplatin and Org. 2766 on rat spinal ganglion neurons. Cancer Res 50: 2437–2442, 1990

    Google Scholar 

  6. Cavaletti G, Tredici G, Marmiroli P, Petruccioli MG, Barajon I, Fabbrica D: Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathol 84: 364–371, 1992

    Google Scholar 

  7. Harder HC, Rosenberg G: Inhibitory effects of antitumor platinum compounds on DNA, RNA and protein synthesis in mammalian cells in vitro. Int J Cancer 6: 207–216, 1970

    Google Scholar 

  8. Pinto AL, Lippard SJ: Binding of the antitumor drug cisdiamminedichloroplatinum (II) (cisplatin) to DNA. Biochem Biophys Acta 780: 167–180, 1985

    Google Scholar 

  9. Huang H, Zhu L, Reid BR, Drobny GP, Hopkins PB: Solution structure of a cisplatin induced DNA interstrand crosslink. Science 270: 1842–1845, 1995

    Google Scholar 

  10. Cece R, Petruccioli MG, Pizzini G, Cavaletti G, Tredici G: Ultrastructural aspects of DRG satellite cell involvement in experimental cisplatin neuronopathy. J Submicrosc Cytol Pathol 27: 417–425, 1995

    Google Scholar 

  11. Apfel SC, Arezzo JC, Lipson LA, Kessle JA: Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 31: 76–80, 1992

    Google Scholar 

  12. Windebank AJ, Smith AG, Russell JW: The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro. Neurology 44: 488–494, 1994

    Google Scholar 

  13. Konings PNM, Makkink WK, van Delft AML, Ruigt GSF: Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro. Brain Res 640: 195–204, 1994

    Google Scholar 

  14. Gao W-Q, Dybdal N, Shinsky N, Murnane A, Schmelzer C, Siegel M, Keller G, Hefti F, Phillips HS, Winslow JW: Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann Neurol 38: 30–37, 1995

    Google Scholar 

  15. Malgrange B, Delree P, Rigo JM, Baron H, Moonen G: Image analysis of neuritic regeneration by adult rat dorsal root ganglion neurons in culture: quantification of the neurotoxicity of anticancer agents and of its prevention by nerve growth factor or basic fibroblast growth factor but not brainderived neurotrophic factor or neurotrophin-3. J Neurosci Methods 53: 111–122, 1994

    Google Scholar 

  16. Gerritsen van der Hoop R, De Koning P, Boven E, Neijt JP, Jennekens FGI, Gispen WH: Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats. Eur J Cancer Clin Oncol 24: 637–642, 1988

    Google Scholar 

  17. Hamers FPT, Pette C, Bravenboer B, Vecht CJ, Neijt JP, Gispen WH: Cisplatin-induced neuropathy in mature rats: effects of the melanocortin-derived peptide ORG 2766. Cancer Chemother Pharmacol 32: 162–166, 1993

    Google Scholar 

  18. Gerritsen van der Hoop R, Hamers FPT, Neijt JP, Veldman H, Gispen WH, Jennekens FGI: Protection against cisplatin induced neurotoxicity by ORG 2766: histological and electrophysiological evidence. J Neurol Sci 126: 109–115, 1994

    Google Scholar 

  19. Hol EM, Mandys V, Sodaar P, Gispen WH, Bär PR: Protection by an ACTH4–9 analogue against the toxic effects of cisplatin and taxol on sensory neurons and glial cells in vitro. J Neurosci Res 39: 178–185, 1994

    Google Scholar 

  20. Di Re F, Bohm S, Oriana S, Spatti GB, Zunino F: Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer. Cancer Chemother Pharmacol 25: 355–360, 1990

    Google Scholar 

  21. Tedeschi M, De Cesare A, Oriana S, Perego P, Silva A, Venturino P, Zunino F: The role of glutathione in combination with cisplatin in the treatment of ovarian cancer. Cancer Treat Rev 18: 253–259, 1991

    Google Scholar 

  22. Hamers FPT, Brakkee JH, Cavalletti E, Tedeschi M, Marmonti L, Pezzoni G, Neijt JP, Gispen WH: Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res 53: 544–549, 1993

    Google Scholar 

  23. Cavaletti G, Minoia C, Schieppati M, Tredici G: Protective effects of glutathione on cisplatin neurotoxicity in rats. Int J Rad Oncol Biol Phys 29: 771–776, 1994

    Google Scholar 

  24. Tredici G, Cavaletti G, Petruccioli MG, Fabbrica D, Tedeschi M, Venturino P: Low-dose glutathione administration in the prevention of cisplatin-induced peripheral neuropathy in rats. Neurotoxicol 15: 701–704, 1994

    Google Scholar 

  25. Cascinu S, Cordella L, Del Ferro E, Fronzoni M, Catalano G: Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. J Clin Oncol 13: 26–32, 1995

    Google Scholar 

  26. Hamers FPT, Gerritse van der Hoop R, Steerenburg PA, Neijt JP, Gispen WH: Putative neurotrophic factors in the protection of cisplatin-induced peripheral neuropathy in rats. Toxicol Appl Pharmacol 111: 514–522, 1991

    Google Scholar 

  27. Wuarin L, Sidell N, de Vellis J: Retinoids increase perinatal spinal cord neuronal survival and astroglial differentiation. Int J Dev Neurosci 8: 317–326, 1990

    Google Scholar 

  28. Wuarin L, Sidell N: Differential susceptibilities of spinal cord neurons to retinoic acid-induced survival and differentiation. Dev Biol 144: 429–435, 1991

    Google Scholar 

  29. van Holst A, Rodriguez-Tabar A, Michaille JJ, Dhouailly D, Bäckström A, Ebendal T, Rohrer H: Retinoic acid-mediated increase in TrkA expression is sufficient to elicit NGF-dependent survival of sympathetic neurons. Mol Cell Neurosci 6: 185–198, 1995

    Google Scholar 

  30. Wion D, Houlgatte R, Barbot N, Barrand P, Dicou E, Brachet P: Retinoic acid increases the expression of NGF gene in mouse L cells. Biochem Biophys Res Commun 149: 510–514, 1987

    Google Scholar 

  31. Haskell BE, Stach RW, Werrbach-Perez K, Perez-Polo JR: Effect of retinoic acid on nerve growth factor receptors. Cell Tissue Res 247: 67–73, 1987

    Google Scholar 

  32. Vogel KS: Development of trophic interactions in the vertebrate peripheral nervous system. Mol Neurobiol 7: 363–382, 1993

    Google Scholar 

  33. Carswell S: The potential for treating neurodegenerative disorders with NGF-inducing compounds. Exp Neurol 124: 36–42, 1993

    Google Scholar 

  34. Rodriguez-Tebar A, Rohrer H: Retinoic acid induced NGF-dependent survival response and high-affinity NGF receptors in immature chick sympathetic neurons. Development 112: 813–820, 1991

    Google Scholar 

  35. Kaplan DR, Matsumoto K, Lucarelli E, Thiele CJ: Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group. Neuron 11: 321–331, 1993

    Google Scholar 

  36. Kobayashi M, Kurihara K, Matsuoka I: Retinoic acid induces BDNF responsiveness of sympathetic neurons by alteration of Trk neurotrophin receptor expression. FEBS Lett 356: 60–65, 1994

    Google Scholar 

  37. Hennekens CH, Mayrent SL, Willett W: Vitamin A, Carotenoids and retinoids. Cancer 58: 1837–1841, 1986

    Google Scholar 

  38. Das NP: Effects of vitamin A and its analogs on nonenzymatic lipid peroxidation in rat brain mitochondria. J Neurochem 52: 585–588, 1989

    Google Scholar 

  39. Jackson GR, Morgan BC, Werrbach-Perez K, Perez-Polo JR: Antioxidant effect of retinoic acid on PC12 rat pheochromocytoma. Int J Dev Neurosci 9: 161–170, 1991

    Google Scholar 

  40. Dragsted LO, Strube M, Larsen JC: Cancer-protective factors in fruits and vegetables: biochemical and biological background. Pharmacol Toxicol 72 (Suppl 1) 116–135, 1993

    Google Scholar 

  41. Gerster H: Anticarcinogenic affect of common carotenoids. Int J Vitam Nutr Res 63: 93–121, 1993

    Google Scholar 

  42. Cece R, Petruccioli MG, Cavaletti G, Barajon I, Tredici G: An ultrastructural study of neuronal changes in dorsal root ganglia (DRG) of rats after chronic cisplatin administrations. Histol Histopathol 10: 837–845, 1995

    Google Scholar 

  43. Boyer M, Raghavan D, Haris PJ, Liecht J, Bleasel A, Walsh C: Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer. J Clin Oncol 8: 21–26, 1990

    Google Scholar 

  44. Hovestadt A, van der Burg MEL, Verbiest HBC, van Putten WLJ, Vecht CJ: The course of neuropathy after cessation of cisplatin treatment, combined with Org2766 or placebo. J Neurol 239: 143–146, 1992

    Google Scholar 

  45. Schmidt Y, Unger JW, Bartke I, Reiter R: Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice. Exp Neurol 132: 16–23, 1995

    Google Scholar 

  46. Levi J, Jacobs C, Kalman SM, McTingue M, Weiner MW: Mechanisms of cisplatinum nephrotoxicity: 2. Effects of sulfhydril groups in rat kidneys. Pharmacol Exp Ther 213: 545–550, 1980

    Google Scholar 

  47. Rosenberg B: Fundamental studies with cisplatin. Cancer 55: 2303–2316, 1985

    Google Scholar 

  48. Hegedüs L, van der Vijgh WJF, Klein I, Kerpel-Fronius S, Pinedo HM: Chemical reactivity of cisplatin bound to human plasma proteins. Cancer Chemother Pharmacol 20: 211–212, 1987

    Google Scholar 

  49. Tay LK, Bregman CL, Masters BA, Williams PD: Effect of cis-diamminedichloroplatinum (II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Cancer Res 48: 2538–2543, 1988

    Google Scholar 

  50. Parti R, Wolf W: Quantitative subcellular distribution of platinum in rats tissues following i.v. bolus and i.v. infusion of cisplatin. Cancer Chemother Pharmacol 26: 188–192, 1990

    Google Scholar 

  51. Russell JW, Windebank AJ, McNiven MA, Brat DJ, Brimijoin WS: Effect of cisplatin and ACTH4-9 on neural transport in cisplatin induced neurotoxicity. Brain Res 676: 258–267, 1995

    Google Scholar 

  52. Barajon I, Bersani M, Quartu M, Del Fiacco M, Cavaletti G, Holst JJ, Tredici G: Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy. Exp Neurol 138: 93–104, 1996

    Google Scholar 

  53. Olson Y: Vascular permeability in the peripheral nervous system. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral Neuropathy. Saunders, Philadelphia 579–597, 1984

    Google Scholar 

  54. Allen DT, Kiernan JA: Permeation of protein from the blood into peripheral nerves and ganglia. Neurosci 59: 755–764, 1994

    Google Scholar 

  55. Cavaletti G, Tredici G, Pizzini G, Minoia C: Tissue platinum concentrations and cisplatin schedules. Lancet ii: 1003, 1990

Download references

Author information

Authors and Affiliations

  1. Istituto di Anatomia Umana, Università degli Studi di Milano, Milano, Italia

    Giovanni Tredici, Stefano Tredici, Davide Fabbrica & Guido Cavaletti

  2. Fondazione S. Maugeri, Clinica del Lavoro e della Riabilitazione, IRCCS, Pavia, Italia

    Claudio Minoia

  3. Clinica Neurologica V, Università degli Studi di Milano, Monza, Italia

    Guido Cavaletti

Authors
  1. Giovanni Tredici
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefano Tredici
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Davide Fabbrica
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claudio Minoia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guido Cavaletti
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tredici, G., Tredici, S., Fabbrica, D. et al. Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration. J Neurooncol 36, 31–40 (1998). https://doi.org/10.1023/A:1005756023082

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005756023082

Search

Navigation